Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· March 25, 2026

Arteris Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026

View original at finance.yahoo.com
Arteris Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026 Arteris, Inc. Arteris joins the ranks of Google, Nvidia, Adidas, Walmart, and more in Fast Company’s annual World’s Most Innovative Companies of 2026 list…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Arteris is focused on solving the industry's toughest challenges as AI and chiplet-based architectures continue to evolve, from automating complex network-on-chip creation to enabling secure, scalable data movement for billions of chips

    60% confidence
  • FlexGen enables teams to generate optimized interconnects in a fraction of the time with significantly improved power, performance, and area results

    60% confidence
  • Arteris is focused on solving the industry's toughest challenges as AI and chiplet-based architectures continue to evolve, from automating complex network-on-chip creation to enabling secure, scalable data movement for billions of chips

    60% confidence
  • Arteris is committed to addressing rapid changes in the semiconductor industry and setting new standards for innovation

    60% confidence
  • FlexGen is the industry's first smart network-on-chip (NoC) IP

    60% confidence
  • Arteris is honored to receive Fast Company recognition as it reflects their commitment to addressing rapid changes in the semiconductor industry and setting new standards for innovation

    60% confidence
  • Arteris is committed to addressing rapid changes in the semiconductor industry and setting new standards for what is possible through innovation

    60% confidence
  • FlexGen is the industry's first smart network-on-chip IP

    60% confidence
  • Arteris is committed to addressing rapid changes in the semiconductor industry and setting new standards for what is possible through innovation

    60% confidence
  • FlexGen enables teams to generate optimized interconnects in a fraction of the time with significantly improved power, performance, and area (PPA) results

    60% confidence
  • Arteris is focused on solving the industry's toughest challenges as AI and chiplet-based architectures continue to evolve

    60% confidence
  • FlexGen enables teams to generate optimized interconnects in a fraction of the time with significantly improved power, performance, and area results

    60% confidence
  • Arteris network-on-chip technology has been shipped in more than 4 billion chips and chiplets for major customers and numerous emerging AI innovators globally

    60% confidence
  • Arteris is focused on solving the industry's toughest challenges as AI and chiplet-based architectures continue to evolve, from automating complex network-on-chip creation to enabling secure, scalable data movement

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com